TP53 mutation and human papilloma virus status of oral squamous cell carcinomas in young adult patients

Oral Diseases

Volumn 20, Issue 6, 2014, Pages 602-608

  Braakhuis, B J M ^a   Rietbergen, M M ^a   Buijze, M ^a   Snijders, P J F ^a   Bloemena, E ^a,b   Brakenhoff, R H ^a   Leemans, C R ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Head and neck cancer; Human papilloma virus; Mutation; Oral cancer; P53; Squamous cell carcinoma; TP53

Indexed keywords

NUCLEOTIDE; PARAFFIN; PROTEIN P16; PROTEIN P53; VIRUS DNA; TP53 PROTEIN, HUMAN;

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER PATIENT; CANCER TISSUE; CLINICAL ARTICLE; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; GENE INSERTION; GENE MUTATION; GENETIC TRAIT; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STOP CODON; WART VIRUS; YOUNG ADULT; GENETICS; ISOLATION AND PURIFICATION; MOUTH TUMOR; MUTATION; PAPILLOMAVIRIDAE; SQUAMOUS CELL CARCINOMA; VIROLOGY;

ADULT; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; MALE; MOUTH NEOPLASMS; MUTATION; PAPILLOMAVIRIDAE; TUMOR SUPPRESSOR PROTEIN P53; YOUNG ADULT;

EID: 84906790609     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/odi.12178     Document Type: Article

References (37)

1. Annertz K, Anderson H, Biorklund A et al (2002). Incidence and survival of squamous cell carcinoma of the tongue in Scandinavia, with special reference to young adults. Int J Cancer 101: 95-99.
2. Braakhuis BJ, Snijders PJ, Keune WJ et al (2004). Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J Natl Cancer Inst 96: 998-1006.
3. Braakhuis BJM, Visser O, Leemans CR (2009a). Oral and oropharyngeal cancer in the Netherlands between 1989 and 2006: increasing incidence, but not in young adults. Oral Oncol 45: E85-E89.
4. Braakhuis BJ, Brakenhoff RH, Meijer CJ et al (2009b). Human papilloma virus in head and neck cancer: the need for a standardised assay to assess the full clinical importance. Eur J Cancer 45: 2935-2939.
5. Castle JT, Cardinali M, Kratochvil FJ et al (1999). P53 and cyclin D1 staining patterns of malignant and premalignant oral lesions in age-dependent populations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88: 326-332.
6. Den Dunnen JT, Antonarakis SE (2001). Nomenclature for the description of human sequence variations. Hum Genet 109: 121-124.
7. El-Mofty SK, Lu DW (2003). Prevalence of human papillomavirus type 16 DNA in squamous cell carcinoma of the palatine tonsil, and not the oral cavity, in young patients - A distinct clinicopathologic and molecular disease entity. Am J Surg Pathol 27: 1463-1470.
8. Hashibe M, Brennan P, Benhamou S et al (2007). Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the international head and neck cancer epidemiology consortium. J Natl Cancer Inst 99: 777-789.
9. Isayeva T, Li Y, Maswahu D et al (2012). Human papillomavirus in non-oropharyngeal head and neck cancers: a systematic literature review. Head Neck Pathol 6(Suppl 1): S104-S120.
10. Kabeya M, Furuta R, Kawabata K et al (2012). Prevalence of human papillomavirus in mobile tongue cancer with particular reference to young patients. Cancer Sci 103: 161-168.
11. Kaminagakura E, Villa LL, Andreoli MA et al (2012). High-risk human papillomavirus in oral squamous cell carcinoma of young patients. Int J Cancer 130: 1726-1732.
12. Koch WM, Lango M, Sewell D et al (1999). Head and neck cancer in nonsmokers: a distinct clinical and molecular entity. Laryngoscope 109: 1544-1551.
13. Lindenbergh-van der Plas M, Brakenhoff RH, Kuik DJ et al (2011). Prognostic significance of truncating TP53 mutations in head and neck squamous cell carcinoma. Clin Cancer Res 17: 3733-3741.
14. Lingen MW, Chang KW, McMurray SJ et al (2000). Overexpression of p53 in squamous cell carcinoma of the tongue in young patients with no known risk factors is not associated with mutations in exons 5-9. Head Neck 22: 328-335.
15. Llewellyn CD, Johnson NW, Warnakulasuriya KA (2001). Risk factors for squamous cell carcinoma of the oral cavity in young people - a comprehensive literature review. Oral Oncol 37: 401-418.
16. van Monsjou HS, Lopez-Yurda MI, Hauptmann M et al (2013). Oral and oropharyngeal squamous cell carcinoma in young patients: the Netherlands Cancer Institute experience. Head Neck 35: 94-102.
17. Olivier M, Langerod A, Carrieri P et al (2006). The clinical value of somatic TP53 gene mutations in 1, 794 patients with breast cancer. Clin Cancer Res 12: 1157-1167.
18. O'Regan EM, Toner ME, Smyth PC et al (2006a). Distinct array comparative genomic hybridization profiles in oral squamous cell carcinoma occurring in young patients. Head Neck 28: 330-338.
19. O'Regan EM, Fan CY, Toner ME et al (2006b). Genetic and epigenetic alteration profiles for p16 in head and neck squamous cell carcinoma in young adults. J Pathol 210 (Suppl S): 49.
20. Petitjean A, Achatz MI, Borresen-Dale AL et al (2007a). TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Oncogene 26: 2157-2165.
21. Petitjean A, Mathe E, Kato S et al (2007b). Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat 28: 622-629.
22. Poeta ML, Manola J, Goldwasser MA et al (2007). Tp53 mutations and survival in squamous-cell carcinoma of the head and neck. N Engl J Med 357: 2552-2561.
23. Rietbergen MM, Leemans CR, Bloemena E et al (2013). Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm. Int J Cancer 132: 1565-1571.
24. Salem A (2010). Dismissing links between hpv and aggressive tongue cancer in young patients. Ann Oncol 21: 13-17.
25. Schantz SP, Yu GP (2002). Head and neck cancer incidence trends in young Americans, 1973-1997, with a special analysis for tongue cancer. Arch Otolaryngol Head Neck Surg 128: 268-274.
26. Shiboski CH, Schmidt BL, Jordan RCK (2005). Tongue and tonsil carcinoma - increasing trends in the us population ages 20-44 years. Cancer 103: 1843-1849.
27. Siegelmann-Danieli N, Ben-Izhack O, Hanlon A et al (2005). P53 alteration in oral tongue cancer is not significantly associated with age at diagnosis or tobacco exposure. Tumori 91: 346-350.
28. Smeets SJ, Hesselink AT, Speel EJ et al (2007). A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 121: 2465-2472.
29. Sobin L, Gospodarowicz M, Wittekind C (2009). TNM classification of malignant tumors, 7th edn. Wiley Blackwell: Chichester, UK.
30. Sorensen DM, Lewark TM, Haney JL et al (1997). Absence of p53 mutations in squamous carcinomas of the tongue in nonsmoking and nondrinking patients younger than 40 years. Arch Otolaryngol Head Neck Surg 123: 503-506.
31. Tabor MP, Van Houten VMM, Kummer JA et al (2002). Discordance of genetic alterations between primary head and neck tumors and corresponding metastases associated with mutational status of the TP53 gene. Genes Chromosomes Cancer 33: 168-177.
32. Tandon S, Tudur-Smith C, Riley RD et al (2010). A systematic review of p53 as a prognostic factor of survival in squamous cell carcinoma of the four main anatomical subsites of the head and neck. Cancer Epidemiol Biomarkers Prev 19: 574-587.
33. Tassone P, Old M, Teknos TN et al (2013). p53-based therapeutics for head and neck squamous cell carcinoma. Oral Oncol 49: 733-737.
34. Toyooka S, Tsuda T, Gazdar AF (2003). The TP53 gene, tobacco exposure, and lung cancer. Hum Mutat 21: 229-239.
35. Xu Y (2008). Induction of genetic instability by gain-of-function p53 cancer mutants. Oncogene 27: 3501-3507.
36. Zandberg DP, Bhargava R, Badin S et al (2013). The role of human papillomavirus in nongenital cancers. CA Cancer J Clin 63: 57-81.
37. van Zeeburg H, Graveland A, Brink A et al (2013). Generation of precursor cell lines from preneoplastic fields surrounding head and neck cancers. Head Neck 35: 568-574.